Features

Betting on politics: the Irish presidency

The Irish presidency has rolled around again. Matthew Partridge looks at how the betting market rates the main contenders.

916-Higgins-634

Higgins is running for re-election

I haven't really covered Irish politics in this column, but the upcoming presidential election looks an interesting opportunity. Unlike America, the Irish presidency is largely symbolic, with real power residing with the taoiseach and parliament. This year incumbent Michael Higgins (who won in the second round in 2011) is running for re-election, and seeking to be the first president to seek two terms in office since amon de Valera in 1966.

Both Ladbrokes and Paddy Power are offering odds on the winner. Paddy Power has the best odds on Higgins at 1/6 (85.7%), but Ladbrokes is the best on four of the other candidates: Sen Gallagher at 13/2 (13.3%), Gavin Duffy at 18/1 (5.3%), Joan Freeman at 28/1 (3.4%) or Liadh N Riada at 33/1 (2.9%). Paddy Power is offering 66/1 on Peter Casey, the sixth contender. Betfair is offering slightly more generous odds on most of the field: 1.22 (81.9%) on Higgins, 9.8 (10.2%) on Gallagher, 22 (4.5%) on Duffy and 40 (2.5%) on Freeman although N Riada is 9.6 (10.4%).

Higgins is well liked, and has the support of three out of the four main Irish parties (Fine Gael, Fianna Fil and Labour). The only poll, conducted last month has him getting 67% of first-preference votes which would be enough for him to win outright without the need to count second preferences. While there are three presidential debates to go, and a minor news story about presidential expenses in the press, I think that you should take Betfair's 1.22 on Higgins.

Recommended

How the Covid-19 vaccine crisis is putting the EU in danger
EU Economy

How the Covid-19 vaccine crisis is putting the EU in danger

The botched coronavirus vaccine campaign will cause long-term harm to the EU's economy, says Matthew Lynn.
4 Apr 2021
How the vaccine wars will harm us all
Global Economy

How the vaccine wars will harm us all

Grabbing and hoarding vaccine supplies, or even manufacturing one’s own, might seem to make sense for a state in an emergency. But the damage done to …
27 Mar 2021
The European Central Bank fumbles its way towards yield curve control
EU Economy

The European Central Bank fumbles its way towards yield curve control

The EU’s economic recovery is faltering, but its bond yields keep rising. That makes things tricky for the European Central Bank, says John Stepek. He…
12 Mar 2021
Vexing vaccine delays hit drug firms
Biotech stocks

Vexing vaccine delays hit drug firms

AstraZeneca and Pfizer are being attacked by the EU over what it claims are delays in delivering the Covid vaccine.
28 Jan 2021

Most Popular

The bitcoin bubble will burst: here’s how to play it
Bitcoin

The bitcoin bubble will burst: here’s how to play it

The cryptocurrency’s price has soared far beyond its fundamentals, says Matthew Partridge. Here, he looks at how to short bitcoin.
12 Apr 2021
Four investment trusts for income investors to buy now
Investment trusts

Four investment trusts for income investors to buy now

Some high-yielding listed lending funds have come through the crisis with flying colours. David Stevenson picks four of the best.
12 Apr 2021
Central banks are rushing to build digital currencies. What are they, and what do they mean for you?
Bitcoin

Central banks are rushing to build digital currencies. What are they, and what do they mean for you?

As bitcoin continues to soar in value, many of the world’s central banks are looking to emulate it by issuing their own digital currencies. But centra…
8 Apr 2021